Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Beyond Histology: A Unified Transcriptomic Atlas Defines Lung Cancer Biologic States and Subtypes.
Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026
Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: June 18, 2025
FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role.
FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role.
Journal: Breast cancer research and treatment
Published: September 07, 2024
Estrogen regulation and functional role of FGFR4 in estrogen receptor positive breast cancer.
Journal: bioRxiv : the preprint server for biology
Published: April 02, 2024
The genomic landscape of lung cancer in never-smokers from the Women's Health Initiative.
Journal: JCI insight
Published: August 14, 2023
Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 23, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.
Journal: Cancer research
Published: August 03, 2021
Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.
Journal: Cancer research
Published: March 01, 2020
FGFR4: A promising therapeutic target for breast cancer and other solid tumors.
Journal: Pharmacology & therapeutics
Published: January 30, 2020
Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma.
Journal: Scientific reports
Published: January 22, 2020
Last Updated: 09/26/2026